MRI in preclinical drug development.

[1]  Graham J. Galloway,et al.  Repeated Three-Dimensional Magnetic Resonance Imaging of Atherosclerosis Development in Innominate Arteries of Low-Density Lipoprotein Receptor-Knockout Mice , 2002, Circulation.

[2]  S. Sarkar,et al.  Disease-modifying activity of SB 273005, an orally active, nonpeptide αvβ3 (vitronectin receptor) antagonist, in rat adjuvant-induced arthritis , 2001 .

[3]  Sheng-Kwei Song,et al.  Improved magnetic resonance imaging detection of prostate cancer in a transgenic mouse model. , 2002, Cancer research.

[4]  M. Fisher,et al.  The penumbra, therapeutic time window and acute ischaemic stroke. , 1995, Bailliere's clinical neurology.

[5]  T. Nelson,et al.  The effect of dexamethasone on tissue water distribution and proton relaxation in Panc02 tumors. , 1987, Magnetic resonance imaging.

[6]  Ryuji Hata,et al.  A Reproducible Model of Middle Cerebral Artery Occlusion in Mice: Hemodynamic, Biochemical, and Magnetic Resonance Imaging , 1998, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[7]  M E Moseley,et al.  Perfusion and diffusion MR imaging of thromboembolic stroke , 1993, Journal of magnetic resonance imaging : JMRI.

[8]  J. Kucharczyk,et al.  Nicardipine reduces ischemic brain injury. Magnetic resonance imaging/spectroscopy study in cats. , 1989, Stroke.

[9]  M. Rudin,et al.  Calcium antagonists reduce the extent of infarction in rat middle cerebral artery occlusion model as determined by quantitative magnetic resonance imaging. , 1986, Stroke.

[10]  Toyoki Mori,et al.  Cilostazol reduces brain lesion induced by focal cerebral ischemia in rats—an MRI study , 2003, Brain Research.

[11]  G. Fagg,et al.  Differing effects of α-difluoromethylornithine and CGP 40116 on polyamine levels and infarct volume in a rat model of focal cerebral ischaemia , 1992, Neuroscience Letters.

[12]  J. Hennig,et al.  PTK787/ZK 222584, a specific vascular endothelial growth factor-receptor tyrosine kinase inhibitor, affects the anatomy of the tumor vascular bed and the functional vascular properties as detected by dynamic enhanced magnetic resonance imaging. , 2002, Cancer research.

[13]  R. Coatney,et al.  Eprosartan reduces cardiac hypertrophy, protects heart and kidney, and prevents early mortality in severely hypertensive stroke-prone rats. , 2001, Cardiovascular research.

[14]  Steven C. R. Williams,et al.  The neuronal nitric oxide synthase inhibitor, TRIM, as a neuroprotective agent: effects in models of cerebral ischaemia using histological and magnetic resonance imaging techniques , 2003, Brain Research.

[15]  Steven C. R. Williams,et al.  Neuroprotection in Ischemia–Reperfusion Injury: An Antiinflammatory Approach Using a Novel Broad-Spectrum Chemokine Inhibitor , 2001, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[16]  N C Huang,et al.  The evolution of acute stroke recorded by multimodal magnetic resonance imaging. , 1993, Magnetic resonance imaging.

[17]  R. W. Hansen,et al.  The price of innovation: new estimates of drug development costs. , 2003, Journal of health economics.

[18]  R. Weissleder.  Scaling down imaging: molecular mapping of cancer in mice , 2002, Nature Reviews Cancer.

[19]  M Chopp,et al.  Diffusion-, T2-, and Perfusion-Weighted Nuclear Magnetic Resonance Imaging of Middle Cerebral Artery Embolic Stroke and Recombinant Tissue Plasminogen Activator Intervention in the Rat , 1998, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[20]  Z. Bhujwalla,et al.  1H NMR spectroscopy of subcutaneous tumors in mice: Preliminary studies of effects of growth, chemotherapy and blood flow reduction , 1992, NMR in biomedicine.

[21]  J. Kucharczyk,et al.  NG-nitro-L-arginine delays the development of brain injury during focal ischemia in rats. , 1995, Stroke.

[22]  J. Fozard,et al.  Pulmonary edema induced by allergen challenge in the rat: Noninvasive assessment by magnetic resonance imaging , 2001, Magnetic resonance in medicine.

[23]  Yoji Yoshida,et al.  Experimental studies of ischemic brain edema , 1986 .

[24]  G. Schlaug,et al.  Enlargement of human cerebral ischemic lesion volumes measured by diffusion‐weighted magnetic resonance imaging , 1997, Annals of neurology.

[25]  P. Bendel,et al.  In vivo studies by magnetic resonance imaging and spectroscopy of the response to tamoxifen of MCF7 human breast cancer implanted in nude mice. , 1991, Cancer communications.

[26]  L. Pitts,et al.  Magnetic resonance imaging in the evaluation of nimodipine-treated acute experimental focal cerebral ischemia. , 1986, Acta radiologica. Supplementum.

[27]  J. Cohn,et al.  Angiotensin-converting enzyme inhibition and beta-adrenoceptor blockade regress established ventricular remodeling in a canine model of discrete myocardial damage. , 1994, Journal of the American College of Cardiology.

[28]  Vasilis Ntziachristos,et al.  High throughput magnetic resonance imaging for evaluating targeted nanoparticle probes. , 2002, Bioconjugate chemistry.

[29]  J. Boehm,et al.  Disease-modifying activity of SB 242235, a selective inhibitor of p38 mitogen-activated protein kinase, in rat adjuvant-induced arthritis. , 2000, Arthritis and rheumatism.

[30]  T. Kent,et al.  Effect of NGF treatment on outcome measures in a rat model of middle cerebral artery occlusion , 1999, Journal of neuroscience research.

[31]  M. Rudin,et al.  Quantitative magnetic resonance imaging of estradiol‐induced pituitary hyperplasia in rats , 1988, Magnetic resonance in medicine.

[32]  R. Hof,et al.  Effect of Spirapril on Left Ventricular Hypertrophy Due to Volume Overload in Rats , 1992, Journal of cardiovascular pharmacology.

[33]  G. Albers,et al.  Expanding the window for thrombolytic therapy in acute stroke. The potential role of acute MRI for patient selection. , 1999, Stroke.

[34]  G. Steinberg,et al.  SNX-111, a novel, presynaptic N-type calcium channel antagonist, is neuroprotective against focal cerebral ischemia in rabbits , 1997, Journal of the Neurological Sciences.

[35]  A. Reggiani,et al.  The neuroprotective activity of the glycine receptor antagonist GV150526: an in vivo study by magnetic resonance imaging. , 2001, European journal of pharmacology.

[36]  B. Roth,et al.  Novel Diketopiperazine Enhances Motor and Cognitive Recovery after Traumatic Brain Injury in Rats and Shows Neuroprotection In Vitro and In Vivo , 2003, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[37]  Anna Moore,et al.  In vivo magnetic resonance imaging of transgene expression , 2000, Nature Medicine.

[38]  D. Gadian,et al.  Monitoring the initial expansion of focal ischaemic changes by diffusion‐weighted MRI using a remote controlled method of occlusion , 1994, NMR in biomedicine.

[39]  S. Sarkar,et al.  Disease-modifying activity of SK&F 106615 in rat adjuvant-induced arthritis. Multiparameter analysis of disease magnetic resonance imaging and bone mineral density measurements. , 1996, Arthritis and rheumatism.

[40]  N. Szeverenyi,et al.  A quantitative one-dimensional magnetic resonance imaging technique in adjuvant arthritis: the assessment of disease progression and indomethacin efficacy. , 1995, The Journal of rheumatology.

[41]  P. Furmanski,et al.  1H-NMR relaxation times and water compartmentalization in experimental tumor models. , 1986, Magnetic resonance imaging.

[42]  L Lasagna,et al.  Cost of innovation in the pharmaceutical industry. , 1991, Journal of health economics.

[43]  T. Reese,et al.  Cytoprotection does not preserve brain functionality in rats during the acute post‐stroke phase despite evidence of non‐infarction provided by MRI , 2000, NMR in biomedicine.

[44]  J. Waterton,et al.  Use of dynamic contrast-enhanced MRI to evaluate acute treatment with ZD6474, a VEGF signalling inhibitor, in PC-3 prostate tumours , 2003, British Journal of Cancer.

[45]  I. Namer,et al.  Reduction of traumatic brain injury-induced cerebral oedema by a free radical scavenger. , 1996, European journal of pharmacology.

[46]  M. Hoehn,et al.  Application of magnetic resonance to animal models of cerebral ischemia , 2001, Journal of magnetic resonance imaging : JMRI.

[47]  Wei Chen,et al.  Effects of pioglitazone on adipose tissue remodeling within the setting of obesity and insulin resistance. , 2001, Diabetes.

[48]  R G Blasberg,et al.  Noninvasive quantitation of cytosine deaminase transgene expression in human tumor xenografts with in vivo magnetic resonance spectroscopy. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[49]  P. Barker,et al.  Tumor trapping of 5-fluorouracil: in vivo 19F NMR spectroscopic pharmacokinetics in tumor-bearing humans and rabbits. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[50]  Christian M. Kerskens,et al.  Reperfusion after Thrombolytic Therapy of Embolic Stroke in the Rat: Magnetic Resonance and Biochemical Imaging , 1998, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[51]  J. Kucharczyk,et al.  MR evaluation of calcium entry blockers with putative cerebroprotective effects in acute cerebral ischaemia. , 1990, Acta neurochirurgica. Supplementum.

[52]  R. Coatney,et al.  Application of serial in vivo magnetic resonance imaging to evaluate the efficacy of endothelin receptor antagonist SB 217242 in the rat carotid artery model of neointima formation. , 1998, Circulation.

[53]  C. Sotak,et al.  A new method to improve in-bore middle cerebral artery occlusion in rats: demonstration with diffusion- and perfusion-weighted imaging. , 1998, Stroke.

[54]  M. Moseley,et al.  Time-course and treatment response with SNX-111, an N-type calcium channel blocker, in a rodent model of focal cerebral ischemia using diffusion-weighted MRI , 1996, Brain Research.

[55]  M. Rudin,et al.  Calcineurin inhibitors FK506 and SDZ ASM 981 alleviate the outcome of focal cerebral ischemic/reperfusion injury. , 1999, The Journal of pharmacology and experimental therapeutics.

[56]  S. Cohen,et al.  Comparison of the effects of new specific azasteroid inhibitors of steroid 5α‐reductase on canine hyperplastic prostate: Suppression of prostatic DHT correlated with prostate regression , 1995, The Prostate.

[57]  N. van Bruggen,et al.  VEGF antagonism reduces edema formation and tissue damage after ischemia/reperfusion injury in the mouse brain. , 1999, The Journal of clinical investigation.

[58]  V. Kupriyanov,et al.  The effects of drugs modulating K+ transport on Rb+ uptake and distribution in pig hearts following regional ischemia: 87Rb MRI study , 2002, NMR in biomedicine.

[59]  Fuhai Li,et al.  Neuroprotective effects of a novel broad‐spectrum cation channel blocker, LOE 908 MS, on experimental focal ischemia: A multispectral study , 1999, Journal of magnetic resonance imaging : JMRI.

[60]  R. Gillies,et al.  Applications of magnetic resonance in model systems: tumor biology and physiology. , 2000, Neoplasia.

[61]  M. Osteaux,et al.  Inhibitory effect of somatostatin analogue RC-160 on the growth of hepatic metastases of colon cancer in rats: a study with magnetic resonance imaging. , 1992, Cancer research.

[62]  B D Ross,et al.  Magnetic resonance methods for measurement of disease progression in rheumatoid arthritis. , 1993, Magnetic resonance imaging.

[63]  L. Hall,et al.  Diffusion-Weighted MRI Used to Detect in Vivo Modulation of Cortical Spreading Depression: Comparison of Sumatriptan and Tonabersat , 2001, Experimental Neurology.

[64]  Brian Middleton,et al.  Dynamic contrast-enhanced MRI of vascular changes induced by the VEGF-signalling inhibitor ZD4190 in human tumour xenografts. , 2003, Magnetic resonance imaging.

[65]  M. Rudin,et al.  Reduction of neural damage in irreversible cerebral ischemia by calcium antagonists. , 1988, Neurochemical pathology.

[66]  J. Mandeville,et al.  Neuroprotection with NBQX in rat focal cerebral ischemia. Effects on ADC probability distribution functions and diffusion-perfusion relationships. , 1997, Stroke.

[67]  N. Fukunaga,et al.  An animal model of cerebral infarction. Homologous blood clot emboli in rats. , 1982, Stroke.

[68]  G. Fagg,et al.  Characterization of the Cerebroprotective Efficacy of the Competitive NMDA Receptor Antagonist CGP40116 in a Rat Model of Focal Cerebral Ischemia: An in vivo Magnetic Resonance Imaging Study , 1993, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[69]  P. Hellings,et al.  Eosinophilic rhinitis accompanies the development of lower airway inflammation and hyper‐reactivity in sensitized mice exposed to aerosolized allergen , 2001, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[70]  S. Nerurkar,et al.  p38 MAPK Inhibitors Ameliorate Target Organ Damage in Hypertension: Part 2. Improved Renal Function as Assessed by Dynamic Contrast-Enhanced Magnetic Resonance Imaging , 2003, Journal of Pharmacology and Experimental Therapeutics.

[71]  J. Fozard,et al.  Resolution of the oedema associated with allergic pulmonary inflammation in rats assessed noninvasively by magnetic resonance imaging , 2003, British journal of pharmacology.

[72]  J Seega,et al.  Diffusion- and T2-weighted imaging: evaluation of oedema reduction in focal cerebral ischaemia by the calcium and serotonin antagonist levemopamil. , 1993, Magnetic resonance imaging.

[73]  R. Hargreaves,et al.  Clinical biomarkers in drug discovery and development , 2003, Nature Reviews Drug Discovery.

[74]  K. Taber,et al.  Magnetic resonance imaging of the efficacy of specific inhibition of 5α‐reductase in canine spontaneous benign prostatic hyperplasia , 1991 .

[75]  H. Körperich,et al.  MRI and MRS studies on the time course of rat brain lesions and the effect of drug treatment: Volume quantification and characterization of tissue heterogeneity by parameter selection , 1993, Magnetic resonance in medicine.

[76]  J. Wettstein,et al.  In vivo neuroprotective effects of ACEA 1021 confirmed by magnetic resonance imaging in ischemic stroke. , 2003, European journal of pharmacology.

[77]  Scott E. Fraser,et al.  In vivo visualization of gene expression using magnetic resonance imaging , 2000, Nature Biotechnology.

[78]  Jean-Claude Baron,et al.  Imaging the ischaemic penumbra , 2004, Current opinion in neurology.

[79]  S. Sarkar,et al.  Application of magnetic resonance imaging for evaluation of the efficacy of SB 217242 in neointimal formation. , 1998, Journal of cardiovascular pharmacology.

[80]  R. Weissleder,et al.  Molecular imaging in drug discovery and development , 2003, Nature Reviews Drug Discovery.

[81]  K. Yu,et al.  Verapamil reduces the size of reperfused ischemically injured myocardium in hypertrophied rat hearts as assessed by magnetic resonance imaging. , 1996, American heart journal.

[82]  P R Allegrini,et al.  Application of magnetic resonance imaging to the measurement of neurodegeneration in rat brain: MRI data correlate strongly with histology and enzymatic analysis. , 1992, Magnetic resonance imaging.

[83]  Tibo Gerriets,et al.  The macrosphere model Evaluation of a new stroke model for permanent middle cerebral artery occlusion in rats , 2003, Journal of Neuroscience Methods.

[84]  R. Coatney,et al.  Use of Diffusion-Weighted MRI and Neurological Deficit Scores to Demonstrate Beneficial Effects of Isradipine in a Rat Model of Focal Ischemia , 1999, Pharmacology.

[85]  G. Schneider,et al.  Lubeluzole following traumatic brain injury in the rat. , 1999, Journal of Neurotrauma.

[86]  M. Chopp,et al.  A New Rat Model of Thrombotic Focal Cerebral Ischemia , 1997, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[87]  N. Beckmann,et al.  Effects of Sandimmune neoral on collagen-induced arthritis in DA rats: characterization by high resolution three-dimensional magnetic resonance imaging and by histology. , 1998, Journal of magnetic resonance.

[88]  C. Sotak,et al.  Glycine site antagonist attenuates infarct size in experimental focal ischemia. Postmortem and diffusion mapping studies. , 1997, Stroke.

[89]  G. Sutherland,et al.  Effect of U74006F on forebrain ischemia in rats. , 1991, Stroke.

[90]  Simon A Roberts.  Drug metabolism and pharmacokinetics in drug discovery. , 2003, Current opinion in drug discovery & development.

[91]  Maythem Saeed,et al.  Noninvasive assessment of the effects of nicorandil on left ventricular volumes and function in reperfused myocardial infarction. , 2002, Cardiovascular research.

[92]  Y. Kiyota,et al.  Beneficial effect of CV-4151 (Isbogrel), a thromboxane A2 synthase inhibitor, in a rat middle cerebral artery thrombosis model. , 1995, Thrombosis research.

[93]  J. Kucharczyk,et al.  Hyperglycemia augments ischemic brain injury: in vivo MR imaging/spectroscopic study with nicardipine in cats with occluded middle cerebral arteries. , 1991, AJNR. American journal of neuroradiology.

[94]  Fuhai Li,et al.  Use of diffusion- and perfusion-weighted magnetic resonance imaging in drug development for ischemic stroke. , 2003, Current drug targets. CNS and neurological disorders.

[95]  T. Reese,et al.  In vivo magnetic resonance methods in pharmaceutical research: current status and perspectives , 1999, NMR in biomedicine.

[96]  T. Kuroiwa,et al.  Evolution of cerebral ischaemia induced by thromboembolism in rats detected by early sequential MR imaging. , 2001, British journal of anaesthesia.

[97]  G. Steinberg,et al.  Correlation of CGS 19755 Neuroprotection against in vitro Excitotoxicity and Focal Cerebral Ischemia , 1995, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[98]  M. Rudin,et al.  From anatomy to the target: Contributions of magnetic resonance imaging to preclinical pharmaceutical research , 2001, The Anatomical record.

[99]  S. Whitebread,et al.  Left ventricular wall stress and sarcoplasmic reticulum Ca(2+)-ATPase gene expression in renal hypertensive rats: dose-dependent effects of ACE inhibition and AT1-receptor blockade. , 1996, Cardiovascular research.

[100]  H. Fujiki,et al.  Effects of OPC-18790, a new positive inotropic agent, on energetics in the ischaemic canine heart: a 31P-MRS study. , 1995, Cardiovascular research.